Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-03-25 @ 6:15 AM
Study NCT ID:
NCT05275205
Status:
COMPLETED
Last Update Posted:
2024-08-07
First Post:
2022-02-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
Sponsor:
Unity Biotechnology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UBX1325-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None